Glucagon-Like Peptide-1 Receptor Agonists and Risk of Melanoma and Nonmelanoma Skin Cancer: A Propensity Score-Matched Cohort Study.

Trulicity (dulaglutide) - Eli Lilly

liraglutide - Generic mfg.

Glucagon-Like Peptide-1 Receptor Agonists and Risk of Melanoma and Nonmelanoma Skin Cancer: A Propensity Score-Matched Cohort Study. (PubMed, Diabetes Obes Metab) - Sep 28, 2026 - No abstract available
Journal • Basal Cell Carcinoma • Diabetes • Genetic Disorders • Metabolic Disorders • Non-melanoma Skin Cancer • Skin Cancer • Solid Tumor • Squamous Cell Carcinoma • Type 2 Diabetes Mellitus

http://www.ncbi.nlm.nih.gov/pubmed/42802295

Cho-Han Chiang; Emre Karayol; Furkan Bahar; Ko-Yun Chang; Yu-Che Lee

Sep 28, 2026